Endoscopists should keep up with the current trends of antithrombotic therapy in other fields

Abstract

Endoscopy plays an important role in the clinical daily practice of diagnosis and treatment in gastrointestinal diseases. Aggressive endoscopists have been developing novel endoscopic procedures for various diseases that had been treated by surgery a few decades ago [1-3]. However, bleedings associated with endoscopic procedures are still inextricable complications and major concerns for endoscopists even though endoscopic procedures are less invasive compared to surgery. On the other hand, as the number of patients receiving antithrombotics is increasing in the clinical daily practice, endoscopists encounter more patients who require endoscopic procedures during antithrombotic therapy [4]. Antithrombotics decrease the risks of thromboembolism although they also increase the risks of gastrointestinal bleeding at the same time. From that standpoint, cessation during periendoscopic periods seems preferable although careless cessations of antithrombotics bring the unfortunate events of thromboembolism. Thus, the management of antithrombotics in such patients during periendoscopic period has remained a great dilemma for endoscopists.

This article is protected by copyright. All rights reserved.

from #Esophageal Cancer via a.lsfakia on Inoreader http://ift.tt/2oWEspn
via IFTTT